Haleon
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$9.28
FAIR PRICE
$11.42
MARGIN
$2.14
NOW AVAILABLE
Get notified when HLN's fair price changes
Push notifications when HLN's valuation shifts. Available on iOS and Android.
FPI RATING
Strong profitability and consistent growth trajectory, but below-average fundamental quality.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$9.14
Fair price × 0.80
DISTANCE
1.5%
Price to entry level
At the current price of $9.28, HLN trades 1.5% above the conservative entry level of $9.14. This entry level represents a 20% margin of safety below the calculated fair price of $11.42 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
Loading chart data...
P/E RATIO HISTORY
Loading chart data...
METHODOLOGY
How we calculate HLN's fair price
Haleon's fair price of $11.42 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $9.28, HLN trades 23.1% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting HLN's risk profile.
RELATIVE · 30%
Comparing HLN's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for HLN, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate HLN's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for HLN.
Explore on BuliosFAQ
What is the fair price of HLN?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Haleon is $11.42. At the current market price of $9.28, HLN trades 23.1% below its calculated fair value.
Is HLN overvalued or undervalued?+
Haleon is currently undervalued based on our valuation model. The stock trades at $9.28, which is 23.1% below the fair price of $11.42. The P/E ratio of 16.1x is a key metric in the valuation.
What is the margin of safety for HLN?+
With a 20% margin of safety applied to the fair price of $11.42, the conservative entry level for HLN is $9.14. At the current market price of $9.28, the stock trades 1.5% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is HLN's fair price updated?+
We update fair price calculations for HLN daily after market close. The current fair price of $11.42 incorporates the latest market data and sector multiples.
What factors affect HLN's fair price calculation?+
HLN's fair price of $11.42 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 16.1x, ROE of 11.9%, and dividend yield of 3.18%.
Is HLN a good buy right now?+
At $9.28, HLN trades 23.1% below our fair value estimate of $11.42. The stock is currently undervalued. ROE stands at 11.9% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does HLN pay dividends?+
HLN has a dividend yield of 3.18%.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.